Hyprevention Overview
- Founded
-
2010
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$3.27M
- Investors
-
3
Hyprevention General Information
Description
Operator of a medical company intended to develop implantable medical devices to address unmet clinical needs. The company's product Y-STRUT is an implantable medical device indicated for internal fixation of proximal femur of patients at risk of osteoporotic fracture and for impeding pathological fracture, enabling clinicians to treat osteoporotic and cancer patients, thus improving patients outcome.
Contact Information
Website
www.hyprevention.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- Xavier Arnozan Hospital
- Avenue du Haut-Lévêque
- 33604 Pessac
- France
+33 05 00 00 00 00
Hyprevention Timeline
Hyprevention Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 07-Apr-2022 | $3.27M | 00.000 | 000.00 | Completed | Generating Revenue |
| 3. Angel (individual) | 28-Sep-2020 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Angel (individual) | 18-Nov-2017 | $101K | $908K | 00.000 | Completed | Generating Revenue |
| 1. Seed Round | 15-Dec-2015 | $807K | $807K | Completed | Generating Revenue |
Hyprevention Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Ordinary | 000,000 | 00.000000 | 000.0 | 000.0 | 00 | 000.0 | 0.000 | |
| Ordinary | 28,838 | $1.100633 | $9.36 | $9.36 | 1x | $9.36 | 3.32% | |
| Ordinary | 59,700 | $1.100633 | $1.6 | $1.6 | 1x | $1.6 | 6.87% |
Hyprevention Patents
Hyprevention Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2015342167-A1 | Implant for stabilizing fractured or non-fractured bones | Granted | 04-Nov-2014 | 0000000000 | |
| JP-2017533759-A | Implants for stabilizing fractured bones or non-fractured bones | Granted | 04-Nov-2014 | 0000000000 | |
| AU-2015342167-B2 | Implant for stabilizing fractured or non-fractured bones | Active | 04-Nov-2014 | 00000000000 | 0 |
| EP-3017780-A1 | Implant for stabilizing fractured or non-fractured bones | Withdrawn | 04-Nov-2014 | 0000000000 | 00 |
| EP-3215037-B1 | Implant for stabilizing fractured or non-fractured bones | Active | 04-Nov-2014 | A61B17/725 |
Hyprevention Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Cecile Vienney | Founder & Chief Executive Officer |
Hyprevention Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Hyprevention Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Be Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Business Angels Switzerland | Angel Group | Minority | 000 0000 | 000000 0 | |
| Expanso Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |